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Resistant hypertension is defined as poorly controlled status of blood pressure despite of optimal use of three or more 
antihypertensive drugs of different classes, including diuretics. Although exact prevalence of resistant hypertension is not 
known, it has been reported to be 12.8% among patients treated with antihypertensive drugs. It is important to evaluate 
a possible secondary cause in patients with resistant hypertension. We report a case of resistant hypertension with renal 
artery segmental stenosis that was not revealed in renal Doppler study. Blood pressure of the patient was well controlled 
after renal balloon angioplasty.
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INTRODUCTION
Resistant hypertension is defined as poorly controlled 
status despite of optimal use of three antihypertensive 
drugs of different classes.1 Although exact prevalence of 
resistant hypertension is not known, it has been reported 
to be as high as 12.8% among patients treated with 
antihypertensive drugs.2 Recently, the incidence of 
resistant hypertension is increasing owing to the increase 
of the elderly population and obesity.1,3 As successful 
treatment require accurate diagnosis, it may be important 
to consider a secondary cause of hypertension in patient 
with resistant hypertension. We report a case of resistant 
hypertension patient with renal artery segmental stenosis, 
despite of three antihypertensive drugs of different classes.
CASE REPORT
A 45 year-old male who was diagnosed with hyper-
tensive retinopathy due to left eye visual disturbance, 
visited an outpatient clinic for evaluation and treatment 
of hypertension. Despite escalating three different classes 
of antihypertensive medications (Losartan 50 mg, Hydro-
chlorothiazide 12.5 mg, Amlodipine besylate 5 mg) for 
6 months, the maximal blood pressure was 210/110 mmHg 
during a follow-up in outpatient clinic. The 24 hour blood 
pressure monitoring showed a mean blood pressure of 
145/86 mmHg and a maximal blood pressure of 175/110 
mmHg. Finally, the patient was diagnosed with resistant 
hypertension, and the patient underwent study for 
secondary cause of hypertension.
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Fig. 1. Adrenal computer tomography (CT) with contrast. 
CT showed decrease in perfusion of left mid and lower pole 
of the kidney. 
 
Fig. 2. Renal angiogram. Prior to angioplasty, left renal angiogram showed segmental stenosis up to 85% (A). The lesion 
was checked by IVUS to confirm the severity due to tortuosity. After balloon angioplasty was done, final angiogram revealed 
<30% residual stenosis without dissection (B). 
The past and family history of the patient were not 
remarkable and the body mass index of the patient was 
within normal limit (22.5 kg/m2). Physical examination 
including abdominal auscultation was not remarkable. The 
electrocardiogram and chest x-ray were within normal 
range and not remarkable. Laboratory study including 
electrolyte, urinary analysis, aldosterone/renin ratio, 
thyroid function test, blood urea nitrogen, and creatinine 
were within normal range. The norepinephrine was slightly 
elevated to 95.0 ug/day (15.0-80.0 ug/day) in the 24 hour 
urine study. However, the plasma metanephrine and 
normetanephrine were 0.32 mmol/L (0-0.5 mmol/L) and 
0.68 mmol/L (0-0.9 mmol/L) respectively, which were both 
within normal range. The echocardiogram showed normal 
function of heart without evidence of coartation of the 
aorta. The patient underwent the renal doppler study for 
screening test of renovascular disease. The renal doppler 
was not significant, revealing right peak systolic velocity 
on proximal and distal portion were 123 cm/s and 126 
cm/s and left peak systolic velocity on proximal and distal 
portion were 83 cm/s and 50 cm/s by renal duplex doppler 
ultrasonography. However, adrenal CT scan for elaborate 
evaluation of secondary hypertension showed decreased 
perfusion of mid and lower pole of left kidney due to 
possibility of renal artery segmental stenosis (Fig. 1). To 
evaluate for renal artery stenosis, the patient underwent 
renal angiography which revealed a severe segmental 
stenotic lesion in left renal artery (Fig. 2A). Balloon 
angioplasties were done on left renal artery segmental 
stenosis several times and the final angiogram showed 
optimal result of <30% residual stenosis without dissection 
(Fig. 2B). After balloon angioplasty of the left renal artery 
segmental stenosis, the followup 24 hour ambulatory 
blood pressure revealed mean blood pressure of 122/80 
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mmHg. During a follow-up 6 months in an outpatient 
clinic, blood pressure was well-controlled only with one 
medication (Amlodipine besylate 5 mg) and the patient 
was doing well without any symptoms.
DISCUSSION
Resistant hypertension is not an uncommon clinical 
problem. Risk factors of resistant hypertension are older 
age, obesity, chronic kidney disease, diabetes, longer 
hypertension duration, and presence of left ventricular 
hypertrophy.4 However, in a relatively young patient with 
sudden development of severe hypertension that is 
resistant to treatment, assessment of secondary cause 
should be performed.
Secondary hypertension is relatively common in patients 
with resistant hypertension.1 Some studies reported 
12.7% of patients referred to a hypertension clinic center 
had a secondary cause of hypertension, although overall 
prevalence is unknown.5 Recent studies suggested that 
the patient with resistant hypertension should be con-
sidered for the secondary cause of hypertension.1,3,6 A 
common secondary cause of resistant hypertension are 
obstructive sleep apnea, renal parenchymal disease, 
primary aldosteronism, renal artery stenosis, and less 
common cause are pheochromatocytoma, cushing’s 
syndrome. There are several clinical characteristics to 
suggest secondary hypertension. Clinical clues of secon-
dary hypertension are young age less than 30 years, 
negative risk factor such as obesity, negative family history, 
and resistant hypertension. Among the causes of secon-
dary hypertension, renal artery stenosis should be ruled 
out if there are clinical clues such as systolic-diastolic 
abdominal bruit, severe hypertension in patients with an 
unexplained atrophic kidney or deterioration of kidney 
function during antihypertensive therapy.7 However, since 
all the patients are not present with specific signs of renal 
artery stenosis, clinical suspicion is necessary in patients 
with resistant hypertension.
An important lesson from this case study is that renal 
artery segmental stenosis may be not detected on 
noninvasive imaging test including renal duplex doppler 
ultrasonography. The gold standard diagnostic tool is renal 
angiography for renal artery stenosis, but in real clinical 
practice, noninvasive test is preferred as initial diagnostic 
test.8 Renal duplex doppler ultrasonography with a 
sensitivity and specificity of 85% and 92% respectively 
is a common noninvasive tool as screening test for 
evaluation of renovascular disease.9 However its limitation 
is operator-dependency and the fact that it is less useful 
for evaluation of distal renal arteries.8 As the  renal duplex 
doppler ultrasonography showed normal range of both 
renal artery peak systolic velocity, it was assumed there 
were no significant stenosis of both renal artery in this 
case.10 CT angiography (CTA) or Magnetic resonance 
angiography (MRA) are the most accurate, noninvasive 
diagnostic tools of renal artery stenosis.11 However, the 
accuracy of CT angiography and MR angiography for 
detecting distal segmental stenotic lesion has been noted 
only 64% for CTA and 62% for MRA respectively. As 
such, the risk of false negative result is more likely to 
happen in distal arterial segmental lesion such as 
fibromuscular dysplasia.12 Therefore, when results of non-
invasive test are inconclusive, renal angiography should 
be considered in cases of high clinical suspicion.
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